D
Devinder S. Bansi
Researcher at Imperial College London
Publications - 11
Citations - 491
Devinder S. Bansi is an academic researcher from Imperial College London. The author has contributed to research in topics: Biliary disease & Cyst. The author has an hindex of 7, co-authored 11 publications receiving 463 citations.
Papers
More filters
Journal ArticleDOI
Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis.
Madhava Pai,Dimitris Zacharoulis,Miroslav Milicevic,Salah Helmy,Long R. Jiao,Nataša Levičar,Paul Tait,Michael S. Scott,Stephen B. Marley,Kevin Jestice,Maria Glibetic,Devinder S. Bansi,Shahid A. Khan,Despina Kyriakou,Christos Rountas,Andrew V. Thillainayagam,Joanna Nicholls,Steen Lindkaer Jensen,Jane F. Apperley,Myrtle Y. Gordon,Nagy A. Habib +20 more
TL;DR: It is safe to mobilize, expand, and reinfuse autologous CD34+ cells in patients with ALC and the clinical and biochemical improvement in the study group is encouraging and warrants further clinical trials.
Journal ArticleDOI
Imaging of liver cancer
Ben Ariff,Claire R Lloyd,Sameer Khan,Mohamed I.F. Shariff,Andrew V. Thillainayagam,Devinder S. Bansi,Shahid A. Khan,Simon D. Taylor-Robinson,Adrian Lim +8 more
TL;DR: This review discusses the application of several imaging techniques in the diagnosis and staging of both hepatocellular carcinoma and cholangiocarcinoma and outlines certain characteristics of benign liver lesions.
Journal ArticleDOI
Proton and phosphorus-31 nuclear magnetic resonance spectroscopy of human bile in hepatopancreaticobiliary cancer.
Shahid A. Khan,I. Jane Cox,Andrew V. Thillainayagam,Devinder S. Bansi,Howard C. Thomas,Simon D. Taylor-Robinson +5 more
TL;DR: These preliminary studies suggest that 1H and 31P NMR spectroscopy of bile may be used to detect differences in phospholipid content between cancer and non-cancer patients, which may have implications for the development of novel diagnostic strategies in hepatopancreaticobiliary cancers.
Journal ArticleDOI
Clinical and imaging experience with yttrium-90 microspheres in the management of unresectable liver tumours.
Long R. Jiao,Teresa Szyszko,Adil Al-Nahhas,Paul Tait,Ruben Canelo,Gordon Stamp,Harpreet Wasan,Lowdell Cp,R Philips,Andrew V. Thillainayagam,Devinder S. Bansi,Domenico Rubello,P. Limongelli,K Woo,Nagy A. Habib +14 more
TL;DR: Yttrium-90 microspheres treatment with SIRT has a significant effect on liver disease in the absence of extrahepatic disease and should be considered for patients with advanced liver cancer.
Journal ArticleDOI
Metabolic profiling of bile in cholangiocarcinoma using in vitro magnetic resonance spectroscopy
Amar W. Sharif,Horace R T Williams,Temi Lampejo,Shahid A. Khan,Devinder S. Bansi,David Westaby,Andrew V. Thillainayagam,Howard C. Thomas,I. Jane Cox,Simon D. Taylor-Robinson +9 more
TL;DR: Preliminary data suggest that altered bile acid and PtC metabolism play an important role in CCA aetiopathogenesis and that specific metabolites may have potential as future biomarkers.